CivicKnodeCivicKnowA project of CivicKnode
Sign in

HB 1470

EnactedCrossfile SB 839
Add to calendar

Medical Assistance Programs - Drug Dispensing - Cost-of-Dispensing Survey

Sponsor: Bonnie Cullison (District 19)Committee: HealthSubject: Health Care Facilities and RegulationStatus: Approved by the Governor - Chapter 709 (as of Sep 4, 2026)

What this bill does

Official synopsis

Requiring, beginning in 2026, the Maryland Department of Health to conduct the in-State cost-of-dispensing survey at least every 3 years; and requiring the Department to report the results of the survey to the General Assembly by December 1 in each year the survey is required.

AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.

Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.

Testimony (7)

MGA witness list
FAV 6FavorableUNF 1Unfavorable
PositionWitnessOrganizationTestimony
FAVCullison, BonnieDelegate Bonnie CullisonWritten (PDF)
FAVMcDonough, CaitlinlobbyistHJMOral
FAVHorton, AliyahlobbyistMaryland Pharmacists AssociationOral
FAVWienner, StephenMt. Vernon PharmacyOral + Written (PDF)
FAVPaddy, MichaellobbyistPublic Policy PartnersOral
FAVDelegate Cullison, Delegate CullisonlegislatorIndividualOral
UNFLynch, MeghanMaryland Department of HealthWritten (PDF)

Organizations on record

Registered lobbyists who testified

FAVMcDonough, CaitlinHJMRegistered for: AbbVie Inc.; Aligned Data Centers; American Academy of Anesthesiology Assistants, Inc.; Associated Builders & Contractors; Association of Independent Midwives of Maryland (AIMM); Baltimore Gas and Electric Company
FAVHorton, AliyahMaryland Pharmacists AssociationRegistered for: Maryland Pharmacists Association
FAVPaddy, MichaelPublic Policy PartnersRegistered for: American Cancer Society Cancer Action Network; Campaign to Protect Patient Health d/b/a Value of Care Coalition; Chase Brexton Health System; Diabetes Patient Advocacy Coalition; Gaudenzia, Inc.; Gilead Sciences, Inc.